Pharmabiz7h
Centre abdicates its constitutional obligation, criticises patients and experts on SMA issue
Centre abdicates its constitutional obligation, criticises patients and experts on SMA issue: Our Bureau, New Delhi Friday, January 24, 2025, 18:15 Hrs [IST] Patients and public h ...
Pharmabiz8h
Genprex starts patient dosing in phase 2 expansion portion of Acclaim-3 study of Reqorsa Gene Therapy in combo with Tecentriq to treat SCLC
Genprex starts patient dosing in phase 2 expansion portion of Acclaim-3 study of Reqorsa Gene Therapy in combo with Tecentriq to treat SCLC: Austin, Texas Friday, January 24, 2025 ...
Pharmabiz11h
IITH with NIMS unveils India’s digital pathology dataset, paves way for disease diagnosis and treatment
Our Bureau, Bengaluru Friday, January 24, 2025, 14:30 Hrs [IST] ...
Pharmabiz11h
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...
Pharmabiz9h
Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab
Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...
Pharmabiz12h
Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines
Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...
Pharmabiz15h
Jaguar Health begins patient dosing in investigator-initiated POC trial of crofelemer for rare disease indication of MVID
San Francisco, California Friday, January 24, 2025, 11:00 Hrs [IST] ...
Pharmabiz11h
Kelun-Biotech’s novel ADC drug SKB445 receives NMPA approval to treat advanced solid tumours
Kelun-Biotech’s novel ADC drug SKB445 receives NMPA approval to treat advanced solid tumours: Chengdu Sichuan Province, PRC Friday, January 24, 2025, 15:00 Hrs [IST] Sichuan Kel ...
Pharmabiz14h
135 drug samples tested by the Centre and states in December declared as NSQs
The routine regulatory surveillance activity of the Central and State drug regulators has identified a total of 135 drug samples as Not of Standard Quality (NSQ) for the month of December, 2024. For ...
Pharmabiz10h
IDEXX Laboratories launches Cancer Dx panel for early detection of canine lymphoma
IDEXX Laboratories launches Cancer Dx panel for early detection of canine lymphoma: Westbrook, Maine Friday, January 24, 2025, 16:00 Hrs [IST] IDEXX Laboratories, Inc., a global l ...
Pharmabiz10h
Lupin receives US FDA approval for sacubitril and valsartan tablets
Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...
Pharmabiz16h
Genethon & Eukarÿs enter strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies
Genethon & Eukarÿs enter strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies: Evry, France Friday, January 24, 2025, ...